The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Scientific and therapeutic advances in antiplatelet therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Steinhubl, S. R., Berger, P. B., Mann III, J. T., Fry, E. T. A., DeLago, A., Wilmer, C., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,078
Self-citationSleight, R. B., Sleight, P., Parish, S., Appleby, P. N., Collins, R., & Baigent, C. (1988) · PubMed · Cited by 2,868
Mehta, S. R., Yusuf, S., Peters, R. J., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., Malmberg, K., Rupprecht, H.-J., Zhao, F., Chrolavicius, S., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05701-4 · Cited by 2,809
Cited by
A shear gradient–dependent platelet aggregation mechanism drives thrombus formation
Nesbitt, W. S., Westein, E., Tovar-Lopez, F. J., Tolouei, E., Mitchell, A., Fu, J., Carberry, J., Fouras, A., & Jackson, S. P. (2009) · Nature Medicine · doi:10.1038/nm.1955 · Cited by 862
The growing complexity of platelet aggregation
Jackson, S. P. (2007) · Blood · doi:10.1182/blood-2006-12-027698 · Cited by 737
Activation of Platelet Function Through G Protein–Coupled Receptors
Offermanns, S. (2006) · Circulation Research · doi:10.1161/01.res.0000251742.71301.16 · Cited by 725
Platelet-neutrophil-interactions: Linking hemostasis and inflammation
Zarbock, A., Polanowska-Grabowska, R. K., & Ley, K. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.06.001 · Cited by 651
Integrins: dynamic scaffolds for adhesion and signaling in platelets
Shattil, S. J., & Newman, P. J. (2004) · Blood · doi:10.1182/blood-2004-04-1257 · Cited by 601
Kastrati, A., Mehilli, J., Schühlen, H., Dirschinger, J., Dotzer, F., ten Berg, J. M., Neumann, F.-J., Bollwein, H., Volmer, C., Gawaz, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031859 · Cited by 567
Hankey, G. J., & Eikelboom, J. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68040-9 · Cited by 505
Platelets: Physiology and Biochemistry
Jurk, K., & Kehrel, B. E. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-916671 · Cited by 497
Fattori, V., Hohmann, M., Rossaneis, A., Pinho-Ribeiro, F., & Verri, W. (2016) · Molecules · doi:10.3390/molecules21070844 · Cited by 479
Platelet physiology and thrombosis
Andrews, R. K., & Berndt, M. C. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.07.020 · Cited by 445
Aspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance
Cattaneo, M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145980.39477.a9 · Cited by 411
Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors
Johnson, D. S., Weerapana, E., & Cravatt, B. F. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.21 · Cited by 387
Kleinschnitz, C., Pozgajova, M., Pham, M., Bendszus, M., Nieswandt, B., & Stoll, G. (2007) · Circulation · doi:10.1161/circulationaha.107.691279 · Cited by 379
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
von Hundelshausen, P., Koenen, R. R., Sack, M., Mause, S. F., Adriaens, W., Proudfoot, A. E. I., Hackeng, T. M., & Weber, C. (2005) · Blood · doi:10.1182/blood-2004-06-2475 · Cited by 373
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
Meadows, T. A., & Bhatt, D. L. (2007) · Circulation Research · doi:10.1161/01.res.0000264509.36234.51 · Cited by 351
Self-citationMünzel, T., Feil, R., Mülsch, A., Lohmann, S. M., Hofmann, F., & Walter, U. (2003) · Circulation · doi:10.1161/01.cir.0000094403.78467.c3 · Cited by 316
Savi, P., Zachayus, J.-L., Delesque-Touchard, N., Labouret, C., Hervé, C., Uzabiaga, M.-F., Pereillo, J.-M., Culouscou, J.-M., Bono, F., Ferrara, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510446103 · Cited by 317
Platelets as Cellular Effectors of Inflammation in Vascular Diseases
Rondina, M. T., Weyrich, A. S., & Zimmerman, G. A. (2013) · Circulation Research · doi:10.1161/circresaha.113.300512 · Cited by 312
Aspirin and clopidogrel resistance: an emerging clinical entity
Wang, T. H., Bhatt, D. L., & Topol, E. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi684 · Cited by 309
Self-citationP2 receptors, platelet function and pharmacological implications
Gachet, C. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-11-0673 · Cited by 297
REGULATION OF PLATELET FUNCTIONS BY P2 RECEPTORS
Gachet, C. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141207 · Cited by 295
Protease-Activated Receptors in Cardiovascular Diseases
Leger, A. J., Covic, L., & Kuliopulos, A. (2006) · Circulation · doi:10.1161/circulationaha.105.574830 · Cited by 289
Peptide therapeutics from venom: Current status and potential
Pennington, M. W., Czerwinski, A., & Norton, R. S. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.09.029 · Cited by 278
Feil, R., Lohmann, S. M., de Jonge, H., Walter, U., & Hofmann, F. (2003) · Circulation Research · doi:10.1161/01.res.0000100390.68771.cc · Cited by 271
G13 is an essential mediator of platelet activation in hemostasis and thrombosis
Moers, A., Nieswandt, B., Massberg, S., Wettschureck, N., Grüner, S., Konrad, I., Schulte, V., Aktas, B., Gratacap, M.-P., Simon, M. I., et al. (2003) · Nature Medicine · doi:10.1038/nm943 · Cited by 264
Platelets in Inflammatory Bowel Disease: Clinical, Pathogenic, and Therapeutic Implications
Danese, S., Motte, C. D. L., & Fiocchi, C. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04129.x · Cited by 253
Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice
Deppermann, C., Cherpokova, D., Nurden, P., Schulz, J.-N., Thielmann, I., Kraft, P., Vögtle, T., Kleinschnitz, C., Dütting, S., Krohne, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69210 · Cited by 200
Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase
Gambaryan, S., Geiger, J., Schwarz, U. R., Butt, E., Begonja, A., Obergfell, A., & Walter, U. (2004) · Blood · doi:10.1182/blood-2003-09-3349 · Cited by 107
Narizhneva, N. V., Byers-Ward, V. J., Quinn, M. J., Zidar, F. J., Plow, E. F., Topol, E. J., & Byzova, T. V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311090200 · Cited by 47
Self-citation
Metadata
- Authors
- Bhatt, D. L., & Topol, E. J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-01
- Volume
- 2
- Issue
- 1
- Pages
- 15-28
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2007046037
- Cited by
- 407
- References
- 139
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.